Drug · DIN 02370484
SAMSCA
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 25, 2011.
- Drug Identification Number (DIN)
- 02370484
- Company (DIN owner)
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tolvaptan C03XA01
- Class
- Human
- Record last updated
- June 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TOLVAPTAN | 60 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 25, 2011: NOC 12536New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “samsca”. A notice may cover another product or only some lots: read it to see what it covers.
- SAMSCA (tolvaptan) - Potential Risk of Liver Damage - For Health ProfessionalsMarch 1, 2013 · Drugs · Product safety
- SAMSCA (tolvaptan) - Potential Risk of Liver Damage - For the PublicMarch 1, 2013 · Drugs
Other DINs named SAMSCA
- DIN 02370468 · Marketed
- DIN 02370476 · Marketed